Life Science Today

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.

Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Scorpion & AstraZeneca, ABL & Sanofi, Vertex, Cochlear, Vaxcyte

Oncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccines

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Scorpion & AstraZeneca
ABL & Sanofi
Vertex
Cochlear
Vaxcyte

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Stryker + Vocera, Merck KGaA + Exelead, BeiGene, Eikon

Devices with tech enablement, nano particles, Chinese approvals, and a massive series B for  biotechnology

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Stryker + Vocera
Merck KGaA + Exelead
BeiGene
Eikon

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Announcements, Novartis + Gyroscope, Leo, Biogen

We’ve got a new name, gene therapy buyout, a lion of an approval, and an in-escapable spotlight.

 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
Novartis + Gyroscope
Leo
Biogen
Biogen 2

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

The Niche Episode 081 – CSL + Vifor, Oracle + Cerner, Calliditas, Omega Funds

Acquiring the acquired, EHR acquisition, first approvals, and a new fund for the new year

Find out more at
https://thenichepod.com

Story References
CSL + Vifor
Oracle + Cerner
Calliditas
Omega

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

 

The Niche Episode 080 – Microsoft + Nuance, Roche + Recursion, Heron, 1E, Alvotech

Antitrust AI, development AI, expanded approval, mega seeds, and biosimilar SPACs

Find out more at
https://thenichepod.com

Story References
Microsoft + Nuance
Roche + Recursion
Heron
1E
Alvotech 

Music by Luke Goodson

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

 

The Niche Episode 079 – Vifor + Sanifit + Inositec, Kura, Takeda, Aadi, BioCryst, USDA

Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer.

Find out more at
https://thenichepod.com

Story References
Vifor + Sanifit + Inositec
Kura
Differential Syndrome
Takeda
Aadi
BioCryst
USDA

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

Responses

About Instructor

If you'd like to comment on this course or lecture please Register or Login.

THIS CONTENT IS FOR

Registered Users

Please login or register to continue.